AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie total Provisions for Rebates and Chargebacks ($B)
Form 10-K Item 7 MD&A Gross Margin & Rebates Rollforward
Latest, FY2025
65.10
Period ended Dec 31, 2025
Change on a year earlier
+9.8%
59.30 in FY2024
History
8 years
Since FY2018
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Provisions for Rebates and Chargebacks ($B) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 65.10 | +9.8% | Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 59.30 | +4.4% | Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 56.80 | +37.2% | Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 41.40 | +22.1% | Form 10-K (abbv-20241231.htm, filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 33.90 | +25.6% | Form 10-K (abbv-20231231.htm, filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 27.00 | +43.6% | Form 10-K (abbv-20221231.htm, filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 18.80 | +14.6% | Form 10-K (abbv-20211231.htm, filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 16.40 | – | Form 10-K (abbv-20201231.htm, filed 2021-02-19) ↗ |
Breakdown
What makes up total provisions for rebates and chargebacks ($b)
Cite this data
StockData. (2026). AbbVie Total Provisions for Rebates and Chargebacks ($B), annual FY2018–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gtn_tot_prov_b
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.